首页> 美国卫生研究院文献>California Medicine >Responses of Previously Reinfected Rubella Vaccinees to Challenge with Brown Strain Rubella Virus
【2h】

Responses of Previously Reinfected Rubella Vaccinees to Challenge with Brown Strain Rubella Virus

机译:先前再感染的风疹疫苗对棕色菌株风疹病毒攻击的反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The responses of seven hpv-77 rubella vaccinees to initial challenge with “wild” rubella virus have been compared with their responses to rechallenge with Brown strain rubella virus and to the responses of five “natural” immunes to initial Brown strain challenge. Previous exposure to “wild” rubella virus 220 days post vaccine-induced immunity had resulted in six of the seven vaccinees experiencing asymptomatic reinfection. On “rechallenge” none of the previously “reinfected vaccine immunes” demonstrated clinical, virologic or serologic evidence of reinfection. These data are consistent with the conclusion that persons with vaccine-induced immunity may be assured of more prolonged and solid immunity to rubella without having to suffer the clinical disease if they are reinfected with nonattenuated rubella virus. Rigidly controlled experiments, designed to study the practicality and safety of immunization with live rubella vaccine(s), followed by deliberate challenge of vaccinees with “wild” or low tissue culture passage rubella virus, seem warranted. In addition, these data indicate that it is imperative that a distinction should be made between “vaccine immunes” and previously “reinfected vaccine immunes” in any evaluation of long term rubella vaccine(s) efficacy and vaccine-induced antibody decay.
机译:比较了七种hpv-77风疹疫苗对“野生”风疹病毒初始攻击的反应,其对布朗菌株风疹病毒再激发的反应以及对初始布朗菌株挑战的五种“天然”免疫的反应。疫苗诱导的免疫后220天,先前暴露于“野生”风疹病毒中,导致七种疫苗中的六种经历了无症状再感染。在“再挑战”中,以前的“再感染疫苗免疫”均未显示出再感染的临床,病毒学或血清学证据。这些数据与以下结论是一致的:如果用未减毒的风疹病毒再次感染,可以确保具有疫苗诱导免疫力的人对风疹具有更长时间和更强的免疫力,而不必患临床疾病。似乎有必要进行严格控制的实验,以研究用风疹活疫苗进行免疫的实用性和安全性,然后故意用“野生”或低组织培养传代风疹病毒对疫苗进行攻击。此外,这些数据表明,在对风疹疫苗的长期疗效和疫苗诱导的抗体衰减进行任何评估时,必须区分“疫苗免疫”和以前的“重新感染的疫苗免疫”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号